Bacterial expression of a designed single‐chain IL‐10 prevents severe lung inflammation

Abstract Interleukin‐10 (IL‐10) is an anti‐inflammatory cytokine that is active as a swapped domain dimer and is used in bacterial therapy of gut inflammation. IL‐10 can be used as treatment of a wide range of pulmonary diseases. Here we have developed a non‐pathogenic chassis (CV8) of the human lun...

Full description

Saved in:
Bibliographic Details
Main Authors: Ariadna Montero‐Blay, Javier Delgado Blanco, Irene Rodriguez‐Arce, Claire Lastrucci, Carlos Piñero‐Lambea, Maria Lluch‐Senar, Luis Serrano
Format: Article
Language:English
Published: Springer Nature 2023-01-01
Series:Molecular Systems Biology
Subjects:
Online Access:https://doi.org/10.15252/msb.202211037
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849760966399492096
author Ariadna Montero‐Blay
Javier Delgado Blanco
Irene Rodriguez‐Arce
Claire Lastrucci
Carlos Piñero‐Lambea
Maria Lluch‐Senar
Luis Serrano
author_facet Ariadna Montero‐Blay
Javier Delgado Blanco
Irene Rodriguez‐Arce
Claire Lastrucci
Carlos Piñero‐Lambea
Maria Lluch‐Senar
Luis Serrano
author_sort Ariadna Montero‐Blay
collection DOAJ
description Abstract Interleukin‐10 (IL‐10) is an anti‐inflammatory cytokine that is active as a swapped domain dimer and is used in bacterial therapy of gut inflammation. IL‐10 can be used as treatment of a wide range of pulmonary diseases. Here we have developed a non‐pathogenic chassis (CV8) of the human lung bacterium Mycoplasma pneumoniae (MPN) to treat lung diseases. We find that IL‐10 expression by MPN has a limited impact on the lung inflammatory response in mice. To solve these issues, we rationally designed a single‐chain IL‐10 (SC‐IL10) with or without surface mutations, using our protein design software (ModelX and FoldX). As compared to the IL‐10 WT, the designed SC‐IL10 molecules increase the effective expression in MPN four‐fold, and the activity in mouse and human cell lines between 10 and 60 times, depending on the cell line. The SC‐IL10 molecules expressed in the mouse lung by CV8 in vivo have a powerful anti‐inflammatory effect on Pseudomonas aeruginosa lung infection. This rational design strategy could be used to other molecules with immunomodulatory properties used in bacterial therapy.
format Article
id doaj-art-4e63f045fc02418b846daa55c2ead9d6
institution DOAJ
issn 1744-4292
language English
publishDate 2023-01-01
publisher Springer Nature
record_format Article
series Molecular Systems Biology
spelling doaj-art-4e63f045fc02418b846daa55c2ead9d62025-08-20T03:06:10ZengSpringer NatureMolecular Systems Biology1744-42922023-01-0119112010.15252/msb.202211037Bacterial expression of a designed single‐chain IL‐10 prevents severe lung inflammationAriadna Montero‐Blay0Javier Delgado Blanco1Irene Rodriguez‐Arce2Claire Lastrucci3Carlos Piñero‐Lambea4Maria Lluch‐Senar5Luis Serrano6Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and TechnologyCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and TechnologyCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and TechnologyCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and TechnologyCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and TechnologyCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and TechnologyCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and TechnologyAbstract Interleukin‐10 (IL‐10) is an anti‐inflammatory cytokine that is active as a swapped domain dimer and is used in bacterial therapy of gut inflammation. IL‐10 can be used as treatment of a wide range of pulmonary diseases. Here we have developed a non‐pathogenic chassis (CV8) of the human lung bacterium Mycoplasma pneumoniae (MPN) to treat lung diseases. We find that IL‐10 expression by MPN has a limited impact on the lung inflammatory response in mice. To solve these issues, we rationally designed a single‐chain IL‐10 (SC‐IL10) with or without surface mutations, using our protein design software (ModelX and FoldX). As compared to the IL‐10 WT, the designed SC‐IL10 molecules increase the effective expression in MPN four‐fold, and the activity in mouse and human cell lines between 10 and 60 times, depending on the cell line. The SC‐IL10 molecules expressed in the mouse lung by CV8 in vivo have a powerful anti‐inflammatory effect on Pseudomonas aeruginosa lung infection. This rational design strategy could be used to other molecules with immunomodulatory properties used in bacterial therapy.https://doi.org/10.15252/msb.202211037infectioninterleukinlive biotherapeuticsmycoplasmaprotein engineering
spellingShingle Ariadna Montero‐Blay
Javier Delgado Blanco
Irene Rodriguez‐Arce
Claire Lastrucci
Carlos Piñero‐Lambea
Maria Lluch‐Senar
Luis Serrano
Bacterial expression of a designed single‐chain IL‐10 prevents severe lung inflammation
Molecular Systems Biology
infection
interleukin
live biotherapeutics
mycoplasma
protein engineering
title Bacterial expression of a designed single‐chain IL‐10 prevents severe lung inflammation
title_full Bacterial expression of a designed single‐chain IL‐10 prevents severe lung inflammation
title_fullStr Bacterial expression of a designed single‐chain IL‐10 prevents severe lung inflammation
title_full_unstemmed Bacterial expression of a designed single‐chain IL‐10 prevents severe lung inflammation
title_short Bacterial expression of a designed single‐chain IL‐10 prevents severe lung inflammation
title_sort bacterial expression of a designed single chain il 10 prevents severe lung inflammation
topic infection
interleukin
live biotherapeutics
mycoplasma
protein engineering
url https://doi.org/10.15252/msb.202211037
work_keys_str_mv AT ariadnamonteroblay bacterialexpressionofadesignedsinglechainil10preventsseverelunginflammation
AT javierdelgadoblanco bacterialexpressionofadesignedsinglechainil10preventsseverelunginflammation
AT irenerodriguezarce bacterialexpressionofadesignedsinglechainil10preventsseverelunginflammation
AT clairelastrucci bacterialexpressionofadesignedsinglechainil10preventsseverelunginflammation
AT carlospinerolambea bacterialexpressionofadesignedsinglechainil10preventsseverelunginflammation
AT marialluchsenar bacterialexpressionofadesignedsinglechainil10preventsseverelunginflammation
AT luisserrano bacterialexpressionofadesignedsinglechainil10preventsseverelunginflammation